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Impact of rapid microbial identiﬁcation directly from positive blood cultures using
matrix-assisted laser desorption/ionization time-of-ﬂight mass spectrometry on patient
management
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Abstract
For septic patients, delaying the initiation of antimicrobial therapy or choosing an inappropriate antibiotic can considerably worsen their
prognosis. This study evaluated the impact of rapid microbial identiﬁcation (RMI) from positive blood cultures on the management of
patients with suspected sepsis. During a 6-month period, RMI by matrix-assisted laser desorption/ionization time-of-ﬂight mass
spectrometry (MALDI-TOF MS) was performed for all new episodes of bacteraemia. For each patient, the infectious disease specialist was
contacted and questioned about his therapeutic decisions made based on the Gram staining and the RMI. This information was collected to
evaluate the number of RMIs that led to a therapeutic change or to a modiﬁcation of the patient’s general management (e.g. fast removal of
infected catheters). During the study period, 277 new episodes of bacteraemia were recorded. In 71.12% of the cases, MALDI-TOF MS
resulted in a successful RMI (197/277). For adult and paediatric patients, 13.38% (21/157) and 2.50% (1/40) of the RMIs, respectively,
resulted in modiﬁcation of the treatment regimen, according to the survey. In many other cases, the MALDI-TOF MS was a helpful tool for
infectious disease specialists because it conﬁrmed suspected cases of contamination, especially in the paediatric population (15/40 RMIs,
37.50%), or suggested complementary diagnostic testing. This study emphasizes the beneﬁts of RMI from positive blood cultures. Although
the use of this technique represents an extra cost for the laboratory, RMI using MALDI-TOF MS has been implemented in our daily practice.
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